ioversol has been researched along with Diabetic Glomerulosclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rudnick, MR | 1 |
| Davidson, C | 1 |
| Laskey, W | 1 |
| Stafford, JL | 1 |
| Sherwin, PF | 1 |
| Narasaki, K | 1 |
| Kini, AS | 1 |
| Mitre, CA | 1 |
| Kamran, M | 1 |
| Suleman, J | 1 |
| Kim, M | 1 |
| Duffy, ME | 1 |
| Marmur, JD | 1 |
| Sharma, SK | 1 |
1 trial available for ioversol and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.
Topics: Aged; Aged, 80 and over; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Diabeti | 2008 |
2 other studies available for ioversol and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
[Contrast-associated nephrotoxicity: ultrastructural and biochemical study in diabetic rats].
Topics: Animals; Contrast Media; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diatrizoate; Iopam | 1997 |
Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam.
Topics: Aged; Atherectomy, Coronary; Cardiac Catheterization; Contrast Media; Diabetic Nephropathies; Dopami | 2002 |